Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis

Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysis

Background: Patients with chronic renal insufficiency on maintenance haemodialysis face an increased risk of COVID-19 induced mortality and impaired vaccine responses. To date, only a few studies have addressed SARS-CoV-2 vaccine elicited immunity in this immunocompromised population. Methods: We as...

Full description

Bibliographic Details
Main Authors: Monika Strengert, Matthias Becker, Gema Morillas Ramos, Alex Dulovic, Jens Gruber, Jennifer Juengling, Karsten Lürken, Andrea Beigel, Eike Wrenger, Gerhard Lonnemann, Anne Cossmann, Metodi V. Stankov, Alexandra Dopfer-Jablonka, Philipp D. Kaiser, Bjoern Traenkle, Ulrich Rothbauer, Gérard Krause, Nicole Schneiderhan-Marra, Georg M.N. Behrens
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:EBioMedicine
Subjects:
SARS-CoV-2
Dialysis
mRNA vaccination
Variants of concern
Protective immunity
Immunocompromised
Online Access:http://www.sciencedirect.com/science/article/pii/S2352396421003170

Internet

http://www.sciencedirect.com/science/article/pii/S2352396421003170

Similar Items